[1]
Romaniuk, M. and Aksonov, P. 2021. Dutasteride 5α-reductase Inhibitor in the Treatment of Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis. Health of Man. 1 (Jun. 2021), 85–90. DOI:https://doi.org/10.30841/2307-5090.1.2021.232534.